Ascribe Bio: $12 Million Series A Raised For Launching Next-Generation Natural Biofungicide
By Amit Chowdhry ● Oct 15, 2025
Ascribe Bio, a biotechnology company developing natural crop protection solutions, announced it has closed an oversubscribed $12 million Series A financing round co-led by Corteva, through its Corteva Catalyst platform, and Acre Venture Partners. Additional participation came from both new and existing investors, including Syngenta Group Ventures, Trailhead Capital, Silver Blue, Cultivation Capital, and The Yield Lab. The funding will drive the global launch of Phytalix, Ascribe’s breakthrough biofungicide, and further advance its small-molecule technology platform for sustainable crop protection.